Cargando...
Pharmacotherapeutics of SARS-CoV-2 Infections
The COVID-19 pandemic has affected more than 38 million people world-wide by person to person transmission of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Therapeutic and preventative strategies for SARS-CoV-2 remains a significant challenge. Within the past several months, effe...
Guardado en:
| Publicado en: | J Neuroimmune Pharmacol |
|---|---|
| Autores principales: | , , , , , , , , , , , , , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Springer US
2021
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7785334/ https://ncbi.nlm.nih.gov/pubmed/33403500 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11481-020-09968-x |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|